Pazoci 400 ( Pazopanib 400 mg)

Pazopanib 400 mg, also referred to as Pazoci 400, is categorized as a kinase inhibitor that physicians prescribe for the management of advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in adults who have already received chemotherapy. It should be noted that the efficacy of Pazopanib 200 mg in the treatment of adipocytic soft tissue sarcoma or gastrointestinal stromal tumors has not been proven, therefore its application is restricted in such situations.

Pazopanib dose: 

1. The medication must be ingested orally at a dosage of 1800 mg once a day, without food, either one hour before or two hours after eating.

2. For individuals with moderate hepatic impairment, the recommended oral dosage is 200 mg of the medication once a day.

Pazopanib buy online

The cost of pazopanib in India is just 5% of the price in other nations where pazopanib brands are available.

Pazopanib side effects management

Pazopanib can induce various adverse effects, such as nausea, vomiting, and diarrhea, experienced by roughly half of all patients. In addition, it may cause changes in hair color, hypertension (which generally arises within the first few weeks of treatment), loss of appetite, hyperglycemia, hypoglycemia, electrolyte imbalances (such as hypocalcemia, hypomagnesemia, and hypophosphatemia), abnormal laboratory test results (including increased levels of AST, ALT, and protein in urine), edema, hair loss or discoloration, altered taste, abdominal pain, rash, fatigue, and bone marrow suppression (including leukopenia, neutropenia, thrombocytopenia, and lymphopenia). In rare instances, it has been associated with potentially lethal liver damage.

Pazopanib PI

To acquire supplementary details regarding the prescription of the medication, please seek assistance from our customer support representative and cite "FDA Prescribing Information" as a reference.